MINI FUTURE LONG - IPSEN | Real-time Euronext Paris 08:48:34 08/07/2024 pm IST | ||
| 1.185 EUR | -5.58% |
|
| Current month | -11.93% | ||
| 1 month | -32.16% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
| Date | Price | Change |
|---|---|---|
| 08/24/08 | 1.185 | -5.58% |
| 05/24/05 | 1.255 | -11.93% |
| 04/24/04 | 1.425 | +9.20% |
| 03/24/03 | 1.305 | -6.45% |
| 02/24/02 | 1.395 | -2.79% |
Real-time Euronext Paris
Last update July 08, 2024 at 08:48 pm IST
More quotesStatic data
| Product type | Knock-Out mit Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | 
BNP Paribas
|
| V5WHB | |
| ISIN | FRBNPP04ETE7 |
| Date issued | 21/06/2022 |
| Strike | 86.92 € |
| Maturity | Unlimited |
| Parity | 20 : 1 |
| Emission price | 0.26 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.445 € |
|---|---|
| Lowest since issue | 0.285 € |
| Spread | 0.01 € |
| Spread % | 0.83% |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
111.2
EUR
Average target price
127
EUR
Spread / Average Target
+14.17%
- Stock Market
- Certificates
- V5WHB Certificat
